10.00
price down icon0.40%   -0.06
after-market アフターアワーズ: 10.00
loading
前日終値:
$10.06
開ける:
$10.19
24時間の取引高:
1.45M
Relative Volume:
2.07
時価総額:
$592.20M
収益:
$1.10B
当期純損益:
$83.60M
株価収益率:
6.993
EPS:
1.43
ネットキャッシュフロー:
$132.30M
1週間 パフォーマンス:
-4.30%
1か月 パフォーマンス:
-22.02%
6か月 パフォーマンス:
-24.77%
1年 パフォーマンス:
-39.71%
1日の値動き範囲:
Value
$9.925
$10.39
1週間の範囲:
Value
$9.925
$11.07
52週間の値動き範囲:
Value
$9.20
$16.75

Embecta Corp Stock (EMBC) Company Profile

Name
名前
Embecta Corp
Name
セクター
Healthcare (1118)
Name
電話
(862) 401-0000
Name
住所
1209 ORANGE STREET, WILMINGTON
Name
職員
1,850
Name
Twitter
Name
次回の収益日
2025-11-25
Name
最新のSEC提出書
Name
EMBC's Discussions on Twitter

Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Instruments & Supplies icon
EMBC
Embecta Corp
10.00 595.75M 1.10B 83.60M 132.30M 1.43
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
478.34 176.19B 10.06B 2.88B 2.49B 7.876
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
177.83 51.41B 21.92B 1.76B 2.63B 6.1223
Medical Instruments & Supplies icon
ALC
Alcon Inc
78.54 39.00B 10.19B 1.05B 1.38B 2.1044
Medical Instruments & Supplies icon
MDLN
Medline Inc
44.59 37.48B 27.43B 1.27B 1.01B 1.5829
Medical Instruments & Supplies icon
RMD
Resmed Inc
245.84 37.82B 5.40B 1.49B 1.78B 10.12

Embecta Corp Stock (EMBC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-10 開始されました Mizuho Neutral
2024-12-02 アップグレード Morgan Stanley Underweight → Equal-Weight
2024-11-27 アップグレード BTIG Research Neutral → Buy
2023-10-20 開始されました Wolfe Research Peer Perform
2023-01-06 ダウングレード Morgan Stanley Equal-Weight → Underweight
2022-09-08 開始されました BTIG Research Neutral
2022-08-01 開始されました Morgan Stanley Equal-Weight
2022-06-21 開始されました BofA Securities Underperform
すべてを表示

Embecta Corp (EMBC) 最新ニュース

pulisher
05:47 AM

We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance

05:47 AM
pulisher
Feb 11, 2026

Embecta names CEO Kurdikar as new board chair, picks new lead independent director - Drug Delivery Business

Feb 11, 2026
pulisher
Feb 11, 2026

Embecta Corp. Appoints Devdatt Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director - Quiver Quantitative

Feb 11, 2026
pulisher
Feb 11, 2026

embecta CEO Dev Kurdikar adds chair role as Pomeroy becomes lead director - Stock Titan

Feb 11, 2026
pulisher
Feb 11, 2026

Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15 - Yahoo Finance

Feb 11, 2026
pulisher
Feb 10, 2026

Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction - MSN

Feb 10, 2026
pulisher
Feb 09, 2026

Embecta (NASDAQ:EMBC) Trading Down 5%Should You Sell? - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st

Feb 09, 2026
pulisher
Feb 09, 2026

Why analysts remain bullish on Embecta Corp. stock2025 Earnings Impact & AI Based Buy/Sell Signal Reports - mfd.ru

Feb 09, 2026
pulisher
Feb 08, 2026

Trading the Move, Not the Narrative: (EMBC) Edition - Stock Traders Daily

Feb 08, 2026
pulisher
Feb 08, 2026

Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15 - simplywall.st

Feb 08, 2026
pulisher
Feb 07, 2026

Embecta Earnings Call: U.S. Headwinds, Global Offsets - TipRanks

Feb 07, 2026
pulisher
Feb 06, 2026

3 Healthcare Stocks Paying the Highest Dividends of 2026 - The Motley Fool

Feb 06, 2026
pulisher
Feb 06, 2026

Embecta: Stable Execution, GLP-1–Driven Growth Optionality, and Attractive Valuation Support Buy Rating and $25 Target - TipRanks

Feb 06, 2026
pulisher
Feb 06, 2026

BTIG Research Reiterates "Buy" Rating for Embecta (NASDAQ:EMBC) - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Embecta Corp. (NASDAQ:EMBC) Q1 2026 Earnings Call Transcript - Insider Monkey

Feb 06, 2026
pulisher
Feb 06, 2026

BTIG Reiterates Buy Rating on Embecta (EMBC) with Stable Price T - GuruFocus

Feb 06, 2026
pulisher
Feb 06, 2026

Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline By Investing.com - Investing.com South Africa

Feb 06, 2026
pulisher
Feb 06, 2026

Embecta Corp. (EMBC) Stock Analysis: Navigating a 59% Potential Upside Amid Healthcare Innovations - DirectorsTalk Interviews

Feb 06, 2026
pulisher
Feb 06, 2026

Embecta (EMBC) Margin Rebound And 4.4x P E Challenge Cautious Narratives - Sahm

Feb 06, 2026
pulisher
Feb 05, 2026

Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline - Investing.com Nigeria

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta Corp. (NASDAQ:EMBC) to Issue $0.15 Quarterly Dividend - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta Q1 Earnings Call Highlights - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges By GuruFocus - Investing.com Canada

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta reports Q1 adjusted EPS 71c, consensus 67c - TipRanks

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta (NASDAQ:EMBC) Releases Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta Q1 2026 Earnings Call Transcript - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta Corp. SEC 10-Q Report - TradingView

Feb 05, 2026
pulisher
Feb 05, 2026

Revenue Check: What is the PEG ratio of Embecta CorpQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta (NASDAQ:EMBC) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta stock ticks up on Street-beating Q1 - Drug Delivery Business

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta (EMBC) Q1 2026 Earnings Call Transcript - The Globe and Mail

Feb 05, 2026
pulisher
Feb 05, 2026

EMBC: Q1 revenue met expectations; U.S. headwinds offset by international growth and GLP-1 progress - TradingView

Feb 05, 2026
pulisher
Feb 05, 2026

Earnings call transcript: Embecta Q1 2026 beats earnings estimates, stock rises - Investing.com India

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta (NASDAQ:EMBC) Issues FY 2026 Earnings Guidance - MarketBeat

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta earnings beat by $0.04, revenue topped estimates - Investing.com

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta Corp (NASDAQ:EMBC) Stock Falls 6.5% on Q1 Revenue Miss Despite EPS Beat - ChartMill

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results - TradingView

Feb 05, 2026
pulisher
Feb 05, 2026

EMBECTA ($EMBC) Releases Q1 2026 Earnings - Quiver Quantitative

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta Q1 Earnings Summary & Key Takeaways - Benzinga

Feb 05, 2026
pulisher
Feb 05, 2026

embecta Announces Quarterly Cash Dividend - Bluefield Daily Telegraph

Feb 05, 2026
pulisher
Feb 05, 2026

Embecta Announces Quarterly Cash Dividend - marketscreener.com

Feb 05, 2026
pulisher
Feb 03, 2026

A Look Into Embecta Inc's Price Over Earnings - Benzinga

Feb 03, 2026
pulisher
Feb 02, 2026

Yacktman Asset Management LP Has $30.93 Million Stake in Embecta Corp. $EMBC - MarketBeat

Feb 02, 2026
pulisher
Feb 01, 2026

Embecta shares tumble 49% after InvestingPro’s overvalued warning By Investing.com - Investing.com India

Feb 01, 2026
pulisher
Jan 30, 2026

Quarterly Earnings: Will Embecta Corp stock go up in YEARJuly 2025 Catalysts & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 29, 2026

Embecta (EMBC) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Jan 29, 2026
pulisher
Jan 28, 2026

(EMBC) Volatility Zones as Tactical Triggers - Stock Traders Daily

Jan 28, 2026
pulisher
Jan 27, 2026

Teacher Retirement System of Texas Buys 292,477 Shares of Embecta Corp. $EMBC - MarketBeat

Jan 27, 2026
pulisher
Jan 23, 2026

Embecta (NASDAQ:EMBC) Stock Price Down 6.3%Should You Sell? - MarketBeat

Jan 23, 2026
pulisher
Jan 23, 2026

Big Picture: Is Embecta Corp forming a double bottomRate Cut & Weekly Stock Breakout Alerts - baoquankhu1.vn

Jan 23, 2026

Embecta Corp (EMBC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Embecta Corp (EMBC) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Melcher David F
Director
Feb 25 '25
Buy
13.67
13,000
177,646
76,681
Morris Milton Mayo
Director
Feb 13 '25
Sale
16.38
3,100
50,783
36,133
$75.97
price down icon 6.69%
$183.80
price down icon 6.83%
medical_instruments_supplies COO
$81.70
price down icon 1.64%
$74.90
price down icon 0.26%
medical_instruments_supplies WST
$243.51
price down icon 1.40%
medical_instruments_supplies RMD
$245.84
price down icon 5.28%
大文字化:     |  ボリューム (24 時間):